Dr. Gupta highlights the FDA’s delays in approving critical treatments for cancers like pancreatic cancer and metastatic melanoma, despite promising results. These potential life-saving therapies are being held back, impacting patients with limited options. #FDA #CancerResearch
The FDA recently rejected a metastatic melanoma drug for conditional approval, citing its single arm trial design, despi... https://instagr.am/p/DXkWguAActk/

voteinorout on Instagram: "Dr. Gupta highlights the FDA’s delays in approving critical treatments for cancers like pancreatic cancer and metastatic melanoma, despite promising results. These potential life-saving therapies are being held back, impacting patients with limited options. #FDA #CancerResearch The FDA recently rejected a metastatic melanoma drug for conditional approval, citing its single arm trial design, despite a 40% tumor shrinkage response. This decision is surprising, as similar data was accepted in the past. For pancreatic cancer, an mRNA vaccine showed extraordinary results, with seven out of eight patients surviving past five years. Dr. Gupta emphasizes the urgent need for new options in treating these high-mortality diseases. — Dr. @vinguptaofficial breaks down how the FDA is delaying life-saving treatments for deadly cancers like pancreatic cancer and metastatic melanoma — even with promising results already in hand. Follow meidastouch for more. Help this information get to more voters. 🇺🇸 A well-informed electorate is a prerequisite to Democracy. - Thomas Jefferson"
59 likes, 0 comments - voteinorout on April 25, 2026: "Dr. Gupta highlights the FDA’s delays in approving critical treatments for cancers like pancreatic cancer and metastatic melanoma, despite promising results. These potential life-saving therapies are being held back, impacting patients with limited options. #FDA #CancerResearch The FDA recently rejected a metastatic melanoma drug for conditional approval, citing its single arm trial design, despite a 40% tumor shrinkage response. This decision is surprising, as similar data was accepted in the past. For pancreatic cancer, an mRNA vaccine showed extraordinary results, with seven out of eight patients surviving past five years. Dr. Gupta emphasizes the urgent need for new options in treating these high-mortality diseases. — Dr. @vinguptaofficial breaks down how the FDA is delaying life-saving treatments for deadly cancers like pancreatic cancer and metastatic melanoma — even with promising results already in hand. Follow meidastouch for more. Help this information get to more voters. 🇺🇸 A well-informed electorate is a prerequisite to Democracy. - Thomas Jefferson".



